You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
海思科(002653.SZ):注射用甲潑尼龍琥珀酸鈉、氟哌噻噸美利曲辛片擬中選第七批國採
格隆匯 07-13 21:01

格隆匯7月13日丨海思科(002653.SZ)公佈,公司全資子公司遼寧海思科和公司全資孫公司眉山海思科於2022年07月12日參加了聯採辦組織的第七批全國藥品集中採購的投標工作。公司參與的2個產品注射用甲潑尼龍琥珀酸鈉(40mg;125mg)和氟哌噻噸美利曲辛片(氟哌噻噸0.5mg和美利曲辛10mg)擬中標本次集中採購。

注射用甲潑尼龍琥珀酸鈉適應症:應用於呼吸道疾病、內分泌失調、風濕性疾病、膠原性疾病、過敏反應、神經系統疾病、胃腸道疾病、皮膚病、臟器移植後的排異反應等,特別適用於需要作用強、起效快的急速治療的疾病狀態。擬中選價格:22.16元/盒(規格:40mg*4瓶/盒)、53.00元/盒(規格:125mg*4瓶/盒)。

氟哌噻噸美利曲辛片適應症:用於輕、中度抑鬱和焦慮。神經衰弱,心因性抑鬱,抑鬱性神經官能症,隱匿性抑鬱,心身疾病伴焦慮和情感淡漠,更年期抑鬱,嗜酒及藥癮者的焦躁不安及抑鬱。擬中選價格:29.01元/盒。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account